Gamma/delta T cells in autoimmune keratitis
Gamma/delta T cells in autoimmune keratitis
批准号:
8518338
负责人:
Rebecca L. O'Brien
金额:
$37.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2016-07-31
关键词:
Adoptive TransferAgeAnimal Disease ModelsAnimal ModelAnimalsAntibodiesAntigensAreaAutoimmune ProcessAutoimmunityBeta CellC57BL/10 MouseCD8B1 geneCattleCellsCharacteristicsComplexCorneaCorneal DiseasesDataDevelopmentDiseaseDisease modelEffector CellEquilibriumEyeEye diseasesFailureFemaleFlow CytometryFrequenciesGenesGraft RejectionHealedHumanImmuneImmune responseImmune systemImmunobiologyImmunofluorescence ImmunologicIn VitroIncidenceInfectious AgentInflammationInflammatory ResponseJawKeratitisKeratoplastyKnowledgeLabelLeadLightLymphoidMediatingModelingMusOrganPhenotypePlayPopulationPreparationPreventionRelative (related person)ReportingResearchRoleSiteSpleenT Gamma-Delta LymphocyteT-LymphocyteT-Lymphocyte SubsetsTestingVertebratesVisionanterior chambercell typecytokinehealingimmunogenicimmunoregulationinnovationinterestintravital imagingmouse modelneoplastic cellpreventstem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): All jawed vertebrates so far examined carry both alpha/beta and gamma/delta TCR genes, suggesting that both T cells types are present and important to survival. Although many animals have approximately equal numbers of gamma/delta and alpha/beta T cells, in the lymphoid organs of both mice and humans, the gamma/delta T cells are much less numerous than are alpha/beta T cells. There are a host of additional similarities between the mouse and human immune systems, so perhaps in both, gamma/delta T cells have been reduced to their most essential functions. Gamma/delta T cells have been shown to be important in clearing infectious agents, in the destruction of tumor cells, and in controlling immune and inflammatory responses. In this study, we will examine what causes a high frequency of female mice of the C57Bl/10 strain lacking gamma/delta T cells (B10.TCRdelta-/-) to develop inflammation of the cornea. The fact that keratitis arises spontaneously in these mice suggests that gamma/delta T cells are normally needed to prevent an immune attack on the eye. Our preliminary data indicate that keratitis in these mice is not infectious, but is instead autoimmune, and is mediated by auto aggressive ab T cells. Also, we showed that adoptively transferring a particular gamma/delta T cell subset reduces the incidence of keratitis. In this proposal, we will test the hypothesis that immunoregulatory gamma/delta T cells normally prevent cornea-specific autoreactive alpha/beta T cells from attacking the cornea. Thus, B10.TCRdelta-/- mice would be susceptible to keratitis because these regulatory gamma/delta T cells are missing. The specific aims of this project are: Specific Aim 1 - to test the hypothesis that keratitis-inducing alpha/beta T cells in B10.TCRdelta-/-mice are cornea-specific auto aggressive cells. We will investigate the characteristics of alpha/beta T cells that infiltrate the corneas of keratitic B10.TCRdelta-/- mice, examine the cytokines they produce when activated, and test whether they respond in vitro to corneal antigen. We will also determine which alpha/beta T cells are necessary to transfer the disease, and by intravital imaging whether they directly attack cells in the cornea. Specific Aim 2- to test the hypothesis that gamma/delta T cells which protect against keratitis tolerize disease-inducing alpha/beta cells. We will characterize a population of gamma/delta T cells that normally resides in the cornea, and examine whether splenic gamma/delta T cells that reduce the incidence of keratitis contain similar cells. We will also test whether gamma/delta T cells carry out their protective rol while in the cornea, determine which of the cytokines they produce are critical for their effect. Whether they act directly on alpha/beta T cells will be examined by intravital imaging of the cornea. We will also investigate their ability to induce regulatory alpha/beta T cells, and as well
as to promote healing of the cornea during keratitis. This project is both innovative and relevant
because it focuses on a new small animal model for spontaneous autoimmune keratitis which lacks the drawbacks and limitations of existing small animal models for this disease. Gamma/delta T cells have already been implicated by others in human eye diseases. This project could therefore lead to improvements or refinements in the treatment of corneal disease in humans, and will contribute towards our understanding of immune privilege in the eye. In addition, its findings are likely to reveal unique attributes of gamma/delta T cells that may help o explain why they have been evolutionarily conserved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of gamma/delta T cells in type 1 diabetes
-
批准号:8234758
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2012
-
负责人:Rebecca L. O'Brien
-
依托单位:
Gamma/delta T cells in autoimmune keratitis
-
批准号:8699777
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2012
-
负责人:Rebecca L. O'Brien
-
依托单位:
Gamma/delta T cells in autoimmune keratitis
-
批准号:8372159
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2012
-
负责人:Rebecca L. O'Brien
-
依托单位:
The role of gamma/delta T cells in type 1 diabetes
-
批准号:8432001
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2012
-
负责人:Rebecca L. O'Brien
-
依托单位:
Spontaneous Keratitis in T-Cell Deficient Female Mice
-
批准号:7895290
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2010
-
负责人:Rebecca L. O'Brien
-
依托单位:
Spontaneous Keratitis in T-Cell Deficient Female Mice
-
批准号:8045377
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2010
-
负责人:Rebecca L. O'Brien
-
依托单位:
Discovery and Investigation of Gamma/Delta TCR Ligands
-
批准号:8078500
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2010
-
负责人:Rebecca L. O'Brien
-
依托单位:
Identifying Ligands with Soluble Gamma/Delta TCRs
-
批准号:7140474
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2005
-
负责人:Rebecca L. O'Brien
-
依托单位:
Identifying Ligands with Soluble Gamma/Delta TCRs
-
批准号:6968815
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2005
-
负责人:Rebecca L. O'Brien
-
依托单位:
Spontaneous Corneal Inflammation in gd T cell absence
-
批准号:6814390
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2004
-
负责人:Rebecca L. O'Brien
-
依托单位:
Spontaneous Corneal Inflammation in gd T cell absence
-
批准号:6949900
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2004
-
负责人:Rebecca L. O'Brien
-
依托单位:
The Basis of Functional Variation in Gamma/Delta T cells
-
批准号:7048678
-
项目类别:
-
资助金额:$37.01万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
The Basis of Functional Variation in Gamma/Delta T cells
-
批准号:6849749
-
项目类别:
-
资助金额:$37.9万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS
-
批准号:6632133
-
项目类别:
-
资助金额:$29.8万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS
-
批准号:6511054
-
项目类别:
-
资助金额:$28.93万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
The Basis of Functional Variation in Gamma/Delta T cells
-
批准号:6779962
-
项目类别:
-
资助金额:$37.9万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
The Basis of Functional Variation in Gamma/Delta T cells
-
批准号:7190510
-
项目类别:
-
资助金额:$35.94万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS
-
批准号:2827245
-
项目类别:
-
资助金额:$23.52万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS
-
批准号:6170935
-
项目类别:
-
资助金额:$27.27万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
The Basis of Functional Variation in Gamma/Delta T cells
-
批准号:7929957
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1999
-
负责人:Rebecca L. O'Brien
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: